Abstract
Maturity onset diabetes of the young (MODY) is a metabolic and genetic disorder. It is different from type 1 and type 2 diabetes with low occurrence level (1–2 %) among all diabetes. This disorder is a consequence of β-cell dysfunction. Till date, 11 subtypes of MODY have been identified, and all of them can cause gene mutations. However, very little is known about the gene mapping, molecular phylogenetics, and co-expression among MODY genes and networking between cascades. This study has used latest servers and software such as VarioWatch, ClustalW, MUSCLE, G Blocks, Phylogeny.fr, iTOL, WebLogo, STRING, and KEGG PATHWAY to perform comprehensive analyses of gene mapping, multiple sequences alignment, molecular phylogenetics, protein–protein network design, co-expression analysis of MODY genes, and pathway development. The MODY genes are located in chromosomes-2, 7, 8, 9, 11, 12, 13, 17, and 20. Highly aligned block shows Pro, Gly, Leu, Arg, and Pro residues are highly aligned in the positions of 296, 386, 437, 455, 456 and 598, respectively. Alignment scores inform us that HNF1A and HNF1B proteins have shown high sequence similarity among MODY proteins. Protein–protein network design shows that HNF1A, HNF1B, HNF4A, NEUROD1, PDX1, PAX4, INS, and GCK are strongly connected, and the co-expression analyses between MODY genes also show distinct association between HNF1A and HNF4A genes. This study has used latest tools of bioinformatics to develop a rapid method to assess the evolutionary relationship, the network development, and the associations among eleven MODY genes and cascades. The prediction of sequence conservation, molecular phylogenetics, protein–protein network and the association between the MODY cascades enhances opportunities to get more insights into the less-known MODY disease.
Similar content being viewed by others
References
American Diabetes Association. (2013). Diagnosis and classification of diabetes mellitus. Diabetes Care, 36, S67–S74.
Pradhan, A. (2007). Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Nutrition Reviews, 65, S152–S156.
Tattersall, R. B. (1974). Mild familial diabetes with dominant inheritance. Q J Med., 43, 339–357.
Tattersall, R. B., & Fajans, S. S. (1975). A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes, 24(1), 44–53.
Gardner, D. S., & Tai, E. S. (2012). Clinical features and treatment of maturity onset diabetes of the young (MODY). Diabetes Metab Syndr Obes, 5, 101–108.
American Diabetes Association. (2011). Diagnosis and classification of diabetes mellitus. Diabetes Care, 33, S62–S69.
Hattersley, A., Bruining, J., Shield, J., Njolstad, P., & Donaghue, K. C. (2009). The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes, 10, 33–42.
Molven, A., & Njølstad, P. R. (2011). Role of molecular genetics in transforming diagnosis of diabetes mellitus. Expert Rev Mol Diagn, 11, 313–320.
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001). Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. New England Journal of Medicine, 345, 971–980.
Kropff, J., Selwood, M. P., McCarthy, M. I., Farmer, A. J., & Owen, K. R. (2011). Prevalence of monogenic diabetes in young adults: a community-based, cross-sectional study in Oxfordshire, UK. Diabetologia, 54, 1261–1263.
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., et al. (2010). Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia, 53, 2504–2508.
Yamagata K, Furuta H, Oda N, et al. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1) Nature. 384:458–460.
Yamagata, K., Oda, N., Kaisaki, P. J., et al. (1996). Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature, 384, 455–458.
Vionnet, N., Stoffel, M., Takeda, J., et al. (1992). Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature, 356, 721–722.
Horikawa, Y., Iwasaki, N., Hara, M., et al. (1997). Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nature Genetics, 17, 384–385.
Stoffers, D. A., Ferrer, J., Clarke, W. L., & Habener, J. F. (1997). Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nature Genetics, 17, 138–139.
Kyithar, M. P., Bacon, S., Pannu, K. K., Rizvi, S. R., Colclough, K., Ellard, S., et al. (2011). Identification of HNF1A-MODY and HNF4A-MODY in Irish families: Phenotypic characteristics and therapeutic implications. Diabetes & Metabolism, 37(6), 512–519.
Negahdar, M., Aukrust, I., Johansson, B. B., Molnes, J., Molven, A., Matschinsky, F. M., et al. (2012). GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation. Biochimica et Biophysica Acta, 1822, 1705–1715.
Thanabalasingham, G., Huffman, J. E., Kattla, J. J., Novokmet, M., Rudan, I., et al. (2013). Mutations in HNF1A result in marked alterations of plasma glycan profile. Diabetes, 62(4), 1329–1337.
Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., et al. (1996). Mutations in the hepatocyte nuclear factor-4[alpha] gene in maturity-onset diabetes of the young (MODY1). Nature, 384, 458–460.
Yang, B. T., Dayeh, T. A., Volkov, P. A., Kirkpatrick, C. L., Malmgren, S., Jing, X., et al. (2012). Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Molecular Endocrinology, 26, 1203–1212.
Haumaitre, C., Fabre, M., Cormier, S., Baumann, C., Delezoide, A. L., & Cereghini, S. (2006). Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1beta/MODY5 mutations. Human Molecular Genetics, 5, 2363–2375.
Copeman, J. B., Cucca, F., Hearne, C. M., et al. (1995). Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31–q33. Nature Genetics, 9, 80–85.
Neve, B., Fernandez-Zapico, M. E., Ashkenazi-Katalan, V., et al. (2005). Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. Proceedings of the National Academy of Sciences of the United States of America, 102, 4807–4812.
Raeder, H., Johansson, S., Holm, P. I., et al. (2006). Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nature Genetics, 38, 54–62.
Kooptiwut, S., Plengvidhya, N., Chukijrungroat, T., Sujjitjoon, J., Semprasert, N., Furuta, H., et al. (2012). Defective PAX4 R192H transcriptional repressor activities associated with maturity onset diabetes of the young and early onset-age of type 2 diabetes. Journal of Diabetes and Its Complications, 26, 343–347.
Amara, A., Chadli-Chaieb, M., Ghezaiel, H., Philippe, J., Brahem, R., Dechaume, A., et al. (2012). Familial early-onset diabetes is not a typical MODY in several Tunisian patients. La Tunisie Medicale, 90, 882–887.
Borowiec, M., Liew, C. W., Thompson, R., Boonyasrisawat, W., Hu, J., Mlynarski, W. M., et al. (2009). Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction. Proceedings of the National Academy of Sciences of the United States of America, 106, 14460–14465.
Chin, E. L., da Silva, C., & Hegde, M. (2013). Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations. BMC Genetics, 14, 6.
Pinsker, W., & Sperlich, D. (1984). Cytogenetic mapping of enzyme loci on chromosomes J and U of Drosophila subobscra. Genetics, 108(4), 913–926.
Zeeberg, B. (2002). Shannon information theoretic computation of synonymous codon usage biases in coding regions of human and mouse genomes. Genome Research, 12, 944–955.
Tao, X., & Dafu, D. (1998). The relationship between synonymous codon usage and protein structure. FEBS Letters, 434, 93–96.
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., et al. (2002). Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. Journal of Neuroscience, 22, 1763–1771.
Salvi, M., Sarno, S., Cesaro, L., Nakamura, H., & Pinna, L. A. (2009). Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis. Biochimica et Biophysica Acta, 1793, 847–859.
Peri, S., Navarro, J. D., Amanchy, R., Kristiansen, T. Z., Jonnalagadda, C. K., et al. (2003). Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Research, 13, 2363–2371.
Xenarios, I., Salwinski, L., Duan, X. J., Higney, P., Kim, S. M., et al. (2002). DIP, the Database of Interacting Proteins: A research tool for studying cellular networks of protein interactions. Nucleic Acids Research, 30, 303–305.
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., et al. (1999). KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Research, 27, 29–34.
Joshi-Tope, G., Gillespie, M., Vastrik, I., D’Eustachio, P., Schmidt, E., et al. (2005). Reactome: A knowledgebase of biological pathways. Nucleic Acids Research, 33, 428–432.
Wheeler, D. L., Barrett, T., Benson, D. A., Bryant, S. H., Canese, K., et al. (2007). Database Resources of the National Center for Biotechnology Information. Nucleic Acids Research, 35, D5–D12.
Sayers, E. W., Barrett, T., Benson, D. A., Bolton, E., Bryant, S. H., et al. (2011). Database resources of the National Center for Biotechnology Information. Nucleic Acids Research, 39, D38–D51.
Boeckmann, B., Bairoch, A., Apweiler, R., Blatter, M. C., Estreicher, A., et al. (2003). The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Research, 31, 365–370.
Cheng, Y. C., Hsiao, F. C., Yeh, E. C., Lin, W. J., Tang, C. Y., et al. (2012). VarioWatch: Providing large-scale and comprehensive annotations on human genomic variants in the next generation sequencing era. Nucleic Acids Research, 40, W76–W81.
Edgar, R. C. (2004). MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Research, 32, 1792–1797.
Castresana, G., & Talavera, J. (2007). Improvement of phylogenies after removing divergent and ambiguously aligned blocks from protein sequence alignments. Systematic Biology, 56, 564–577.
Castresana, J. (2000). Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. Molecular Biology and Evolution, 17, 540–552.
Pupko, T., Bell, R. E., Mayrose, I., Glaser, F., & Ben-Tal, N. (2002). Rate4Site: an algorithmic tool for the identification of functional regions in proteins by surface mapping of evolutionary determinants within their homologues. Bioinformatics, 18, S71–S77.
Whelan, S., & Goldman, N. (2001). A general empirical model of protein evolution derived from multiple protein families using a maximum-likelihood approach. Molecular Biology and Evolution, 18, 691–699.
Mayrose, I., Graur, D., Ben-Tal, N., & Pupko, T. (2004). Comparison of site-specific rate-inference methods for protein sequences: empirical Bayesian methods are superior. Molecular Biology and Evolution, 21, 1781–1791.
Dereeper, A., Guignon, V., Blanc, G., Audic, S., Buffet, S., et al. (2008). Phylogeny.fr: Robust phylogenetic analysis for the non-specialist. Nucleic Acids Research, 36, W465–W469.
Holmes, S. (2003). Bootstrapping phylogenetic trees: theory and methods. Statistical Science, 18, 241–255.
Hillis, D. M., & Bull, J. J. (1993). An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. Systematic Biology, 42, 182–192.
Letunic, I., & Bork, P. (2007). Interactive Tree Of Life (iTOL): An online tool for phylogenetic tree display and annotation. Bioinformatics, 23, 127–128.
Schneider, T. D., & Stephens, R. M. (1990). Sequence logos a new way to display consensus sequences. Nucleic Acids Research, 18, 6097–6100.
Crooks, G. E., Hon, G., Chandonia, J. M., & Brenner, S. E. (2004). WebLogo: A sequence logo generator. Genome Research, 14, 1188–1190.
Jensen, L. J., Kuhn, M., Stark, M., Chaffron, S., Creevey, C., et al. (2009). STRING 8—a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Research, 37, 412–416.
Wrzodek, C., Büchel, F., Ruff, M., Dräger, A., & Zell, A. (2013). Precise generation of systems biology models from KEGG pathways. BMC Systems Biology, 7, 15.
Griffiths, A. J. F., Miller, J. H., Suzuki, D. T., et al. (2000). An introduction to genetic analysis (7th ed.). New York: W. H. Freeman.
Vaxillaire, M., Boccio, V., Philippi, A., Vigouroux, C., Terwilliger, J., et al. (1995). A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nature Genetics, 9, 418–423.
Kim, S. H., Ma, X., Weremowicz, S., Ercolino, T., Powers, C., et al. (2004). Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23. Diabetes, 53(5), 1375–1384.
Rothschild, C. B., Akots, G., Hayworth, R., Pettenati, M. J., Rao, P. N., et al. (1993). A genetic map of chromosome 20q12-q13.1: Multiple highly polymorphic microsatellite and RFLP markers linked to the maturity-onset diabetes of the young (MODY) locus. American Journal of Human Genetics, 52(1), 110–123.
Lipman, D. J., Altschul, S. F., & Kececioglu, J. D. (1989). A tool for multiple sequence alignment. Proceedings of the National Academy of Sciences of the United States of America, 86, 4412–4415.
Galán, M., Vincent, O., Roncero, I., Azriel, S., Boix-Pallares, P., et al. (2006). Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability. Biochemical Journal, 393, 389–396.
Deane, C. M., & Lummis, S. C. (2001). The role and predicted propensity of conserved proline residues in the 5-HT3 receptor. Journal of Biological Chemistry, 276, 37962–37966.
Chakraborty, C., Roy, S. S., Hsu, M. J., & Agoramoorthy, G. (2012). Can computational biology improve the phylogenetic analysis of insulin? Computer Methods and Programs in Biomedicine, 108, 860–872.
Harries, L. W., Brown, J. E., & Gloyn, A. L. (2009). Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes. PLoS One, 4(11), e7855.
Chakraborty, C., George Priya Doss, C., Sharma, R., Sahana, S., & Nair, T. S. (2013). Does computational biology help us to understand the molecular phylogenetics and evolution of cluster of differentiation (CD) proteins? Protein Journal, 32, 143–154.
Chakraborty, C., Roy, S. S., Hsu, M. J., & Agoramoorthy, G. (2011). Landscape mapping of functional proteins in insulin signal transduction and insulin resistance: A network-based protein–protein interaction analysis. PLoS One, 6, e16388.
Szklarczyk, D., et al. (2011). The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Research, 39(Database issue), D561–D568.
Mazandu, G. K., & Mulder, N. J. (2011). Scoring protein relationships in functional interaction networks predicted from sequence data. PLoS One, 6, e1860.
Muller, Y. L., Infante, A. M., Hanson, R. L., Love-Gregory, L., Knowler, W., et al. (2005). Variants in hepatocyte nuclear factor 4 are modestly associated with type 2 diabetes in Pima Indians. Diabetes, 54, 3035–3039.
Karim, M. A., Wang, X., Hale, T. C., & Elbein, S. C. (2005). Insulin promoter factor 1 variation is associated with type 2 diabetes in African Americans. BMC Medical Genetics, 6, 37.
Weedon, M. N., Owen, K. R., Shields, B., Hitman, G., Walker, M., et al. (2004). Common variants of the hepatocyte nuclear factor-4 P2 promoter are associated with type 2 diabetes in the U.K. population. Diabetes, 53, 3002–3006.
Butte, A., Tamayo, P., Slonim, D., Golub, T., & Kohane, I. (2000). Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. Proceedings of the National Academy of Sciences of the United States of America, 97, 12182–12186.
Zhou, X., Kao, M., & Wong, W. (2002). Transitive functional annotation by shortest path analysis of gene expression data. Proceedings of the National Academy of Sciences of the United States of America, 99, 12783–12788.
Steffen, M., Petti, A., Aach, J., D’haeseleer, P., & Church, G. (2002). Automated modelling of signal transduction networks. BMC Bioinformatics, 3, 34.
Horvath, S., & Dong, J. (2008). Geometric interpretation of gene coexpression network analysis. PLoS Computational Biology, 4(8), e1000117.
Hegele, R. A. (1997). Small genetic effects in complex diseases: A review of regulatory sequence variants in dyslipoproteinemia and atherosclerosis. Clinical Biochemistry, 30, 183–188.
Knight, J. C. (2005). Regulatory polymorphisms underlying complex disease traits. Journal of Molecular Medicine, 83, 97–109.
Kir, S., Zhang, Y., Gerard, R. D., Kliewer, S. A., & Mangelsdorf, D. J. (2012). Nuclear receptors HNF4α and LRH-1 cooperate in regulating Cyp7a1 in vivo. Journal of Biological Chemistry, 287, 41334–41341.
Doss, C. G. P., Chakraboty, C., Syed Haneef, S. A., NagaSundaram, N., Chen, L., & Zhu, H. (2014). Evolution- and structure-based computational strategy reveals the impact of deleterious missense mutations on MODY 2 (maturity-onset diabetes of the young, type 2). Theranostics, 4(4), 366–385.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chakraborty, C., Bandyopadhyay, S., Doss, C.G.P. et al. Exploring the Genomic Roadmap and Molecular Phylogenetics Associated with MODY Cascades Using Computational Biology. Cell Biochem Biophys 71, 1491–1502 (2015). https://doi.org/10.1007/s12013-014-0372-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-014-0372-z